Skip to main content

Advertisement

Log in

Arthritic psoriasis during natalizumab treatment: a case report and review of the literature

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Deng Y, Chang C, Lu Q (2016) The inflammatory response in psoriasis: a comprehensive review. Clin Rev Allergy Immunol 50(3):377–389. https://doi.org/10.1007/s12016-016-8535-x

    Article  CAS  PubMed  Google Scholar 

  2. Hirahara K, Nakayama T (2016) CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm. Int Immunol 28(4):163–171. https://doi.org/10.1093/intimm/dxw006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Millán-Pascual J, Turpín-Fenoll L, Del Saz-Saucedo P, Rueda-Medina I, Navarro-Muñoz S (2012) Psoriasis during natalizumab treatment for multiple sclerosis. J Neurol 259(12):2758–2760. https://doi.org/10.1007/s00415-012-6713-1

    Article  PubMed  Google Scholar 

  4. Park SJ, Im DS (2017) Sphingosine 1-phosphate receptor modulators and drug discovery. Biomol Ther (Seoul) 25(1):80–90. https://doi.org/10.4062/biomolther.2016.160

    Article  Google Scholar 

  5. Ishii M (2017) Immunology proves a great success for treating autoimmune diseases—a perspective on immunopharmacology: IUPHAR Review 23. Br J Pharmacol 2017 Jul;174(13):1875–1880. doi: https://doi.org/10.1111/bph.13784

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. Lugaresi.

Ethics declarations

Conflict of interest

Dr Veria Vacchiano is involved in clinical trials sponsored by Roche and Biogen. She received travel grants from Genzyme/Sanofi.

Dr Matteo Foschi is involved in a clinical trial sponsored by Roche and Biogen. He received travel grants from Biogen and Genzyme/Sanofi.

Dr Loredana Sabattini is involved in a clinical trial sponsored by Roche and received travel grants from Teva, Almirall, and Biogen.

Dr Cinzia Scandellari received compensation for Advisory Board activities from Genzyme/Sanofi and travel grants from Genzyme/Sanofi, Teva, Merck, and Novartis. Her institution (IRCCS) received research grants from Merck, Novartis Pharma, Roche, and Biogen.

Prof Alessandra Lugaresi has served as a Bayer, Biogen, Genzyme/Sanofi, Merck Serono, Novartis, and Teva Advisory Board Member. She received travel grants and honoraria from Bayer, Biogen, Genzyme, Merck Serono, Novartis, Sanofi, and Teva and her institution received research grants from Almirall, Bayer, Biogen, Merck Serono, Novartis, Sanofi, and Teva. Prof Lugaresi has also received travel and research grants from the Associazione Italiana Sclerosi Multipla.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vacchiano, V., Foschi, M., Sabattini, L. et al. Arthritic psoriasis during natalizumab treatment: a case report and review of the literature. Neurol Sci 39, 181–183 (2018). https://doi.org/10.1007/s10072-017-3112-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-017-3112-5

Navigation